Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam M Murray

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Science Immunology|December 28, 2020
Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infectionCatherine J Reynolds, Leo Swadling, Joseph M Gibbons, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
The Lancet. Rheumatology|May 11, 2024
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trialCarl S Goodyear, Amit Patel, Eleanor Barnes, et al.
Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.
Science (New York, N.Y.)|June 14, 2022
Immune boosting by B.1.1.529 <b>(</b>Omicron) depends on previous SARS-CoV-2 exposureCatherine J Reynolds, Corinna Pade, Joseph M Gibbons, et al.
Pageof 2